Skip to main content

In Vitro and In Vivo Silencing of the Androgen Receptor

  • Protocol
  • First Online:
Book cover Androgen Action

Part of the book series: Methods in Molecular Biology ((MIMB,volume 776))

  • 2307 Accesses

Abstract

The androgen receptor (AR) plays a pivotal role in the progression of prostate cancer from the androgen-dependent to the castration-resistant state, making it a potential target for therapy. In this chapter, we describe the preparation and use of sublines of LNCaP and C4-2 human prostate cancer cells which have been engineered to stably express a doxycycline (DOX)-inducible AR shRNA in order to study the in vitro and in vivo effects of AR knockdown.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Petrylak, D. P., Tangen, C. M., Hussain, M. H., Lara, P. N., Jr., Jones, J. A., Taplin, M. E., Burch, P. A., Berry, D., Moinpour, C., Kohli, M., Benson, M. C., Small, E. J., Raghavan, D., and Crawford, E. D. (2004) Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer, N Engl J Med 351, 1513–1520.

    Article  PubMed  CAS  Google Scholar 

  2. Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., and Sawyers, C. L. (2004) Molecular determinants of resistance to antiandrogen therapy, Nat Med 10, 33–39.

    Article  PubMed  Google Scholar 

  3. Wang, Q., Li, W., Zhang, Y., Yuan, X., Xu, K., Yu, J., Chen, Z., Beroukhim, R., Wang, H., Lupien, M., Wu, T., Regan, M. M., Meyer, C. A., Carroll, J. S., Manrai, A. K., Janne, O. A., Balk, S. P., Mehra, R., Han, B., Chinnaiyan, A. M., Rubin, M. A., True, L., Fiorentino, M., Fiore, C., Loda, M., Kantoff, P. W., Liu, X. S., and Brown, M. (2009) Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer, Cell 138, 245–256.

    Article  PubMed  CAS  Google Scholar 

  4. Gregory, C. W., Fei, X., Ponguta, L. A., He, B., Bill, H. M., French, F. S., and Wilson, E. M. (2004) Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer, J Biol Chem 279, 7119–7130.

    Article  PubMed  CAS  Google Scholar 

  5. Sadar, M. D. (1999) Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways, J Biol Chem 274, 7777–7783.

    Article  PubMed  CAS  Google Scholar 

  6. Cheng, H., Snoek, R., Ghaidi, F., Cox, M. E., and Rennie, P. S. (2006) Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression, Cancer Res 66, 10613–10620.

    Article  PubMed  CAS  Google Scholar 

  7. Snoek, R., Cheng, H., Margiotti, K., Wafa, L. A., Wong, C. A., Wong, E. C., Fazli, L., Nelson, C. C., Gleave, M. E., and Rennie, P. S. (2009) In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumors, Clin Cancer Res 15, 39–47.

    Article  PubMed  CAS  Google Scholar 

  8. Downward, J. (2004) Use of RNA interference libraries to investigate oncogenic signalling in mammalian cells, Oncogene 23, 8376–8383.

    Article  PubMed  CAS  Google Scholar 

  9. Hannon, G. J., and Conklin, D. S. (2004) RNA interference by short hairpin RNAs expressed in vertebrate cells, Methods Mol Biol 257, 255–266.

    PubMed  CAS  Google Scholar 

  10. Taxman, D. J., Livingstone, L. R., Zhang, J., Conti, B. J., Iocca, H. A., Williams, K. L., Lich, J. D., Ting, J. P., and Reed, W. (2006) Criteria for effective design, construction, and gene knockdown by shRNA vectors, BMC Biotechnol 6, 7.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors acknowledge the work of Dr Ladan Fazli, Mary Bowden, and Fariba Ghaidi in the development of these techniques in our lab. We also thank Drs Greg Hannon, Alice Mui, and Rob Kay for providing the plasmids. This work was supported by grants from the Prostate Cancer Foundation and the Canadian Institutes of Health Research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul S. Rennie .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Cheng, H., Leblanc, E., Rennie, P.S. (2011). In Vitro and In Vivo Silencing of the Androgen Receptor. In: Saatcioglu, F. (eds) Androgen Action. Methods in Molecular Biology, vol 776. Humana Press. https://doi.org/10.1007/978-1-61779-243-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-243-4_7

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-61779-242-7

  • Online ISBN: 978-1-61779-243-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics